Alivus Life Sciences Limited (NSE:ALIVUS)

Alivus Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 23, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	108,438	132,481	95,161	48,141	56,215	-
Market Cap Growth	-11.80%	39.22%	97.67%	-14.36%	-	-
Enterprise Value	102,514	128,178	90,913	44,570	52,405	-
Last Close Price	883.50	1075.43	772.54	377.65	408.52	-
PE Ratio	19.97	27.28	20.21	10.31	13.43	-
Forward PE	17.68	23.14	16.54	9.96	11.60	-
PS Ratio	4.32	5.55	4.17	2.23	2.65	-
PB Ratio	3.60	4.70	4.08	2.25	2.74	-
P/TBV Ratio	3.62	4.74	4.11	2.27	2.75	-
P/FCF Ratio	-	58.79	33.44	33.62	12.08	-
P/OCF Ratio	-	33.84	23.01	15.73	9.41	-
PEG Ratio	1.47	1.45	1.12	0.98	0.72	-
EV/Sales Ratio	4.08	5.37	3.98	2.06	2.47	-
EV/EBITDA Ratio	13.21	18.88	13.59	6.97	8.53	-
EV/EBIT Ratio	14.40	20.55	14.61	7.42	9.05	-
EV/FCF Ratio	-	56.88	31.95	31.12	11.26	-
Debt / Equity Ratio	0.02	0.02	0.01	0.01	0.00	1.24
Debt / EBITDA Ratio	0.08	0.08	0.03	0.03	0.00	1.57
Debt / FCF Ratio	-	0.25	0.06	0.14	0.01	2.91
Asset Turnover	-	0.76	0.82	0.84	0.95	1.01
Inventory Turnover	-	1.69	1.64	1.87	2.07	2.02
Quick Ratio	-	3.31	2.64	2.34	3.10	0.66
Current Ratio	-	4.97	4.37	3.73	4.60	1.15
Return on Equity (ROE)	-	18.86%	21.07%	22.28%	29.83%	60.91%
Return on Assets (ROA)	-	12.45%	14.01%	14.52%	16.20%	18.86%
Return on Invested Capital (ROIC)	21.98%	21.18%	23.67%	26.11%	27.58%	27.79%
Return on Capital Employed (ROCE)	-	21.20%	25.80%	27.20%	27.70%	72.40%
Earnings Yield	5.01%	3.67%	4.95%	9.70%	7.45%	-
FCF Yield	-	1.70%	2.99%	2.97%	8.28%	-
Dividend Yield	0.58%	0.46%	2.91%	5.56%	5.14%	-
Payout Ratio	-	-	58.55%	82.64%	30.73%	-
Buyback Yield / Dilution	-0.01%	-0.17%	-0.13%	-4.25%	-9.03%	-
Total Shareholder Return	0.57%	0.30%	2.79%	1.31%	-3.89%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.